A detailed history of Navalign, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Navalign, LLC holds 12,044 shares of BSX stock, worth $1.01 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
12,044
Previous 12,429 3.1%
Holding current value
$1.01 Million
Previous $957,000 5.43%
% of portfolio
0.3%
Previous 0.3%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$72.96 - $84.0 $28,089 - $32,340
-385 Reduced 3.1%
12,044 $1.01 Million
Q2 2024

Jul 30, 2024

SELL
$67.33 - $77.71 $1,346 - $1,554
-20 Reduced 0.16%
12,429 $957,000
Q1 2024

Apr 12, 2024

SELL
$57.6 - $68.62 $21,542 - $25,663
-374 Reduced 2.92%
12,449 $852,000
Q4 2023

Jan 18, 2024

SELL
$48.64 - $57.81 $14,202 - $16,880
-292 Reduced 2.23%
12,823 $741,000
Q3 2023

Oct 10, 2023

SELL
$50.19 - $54.68 $24,593 - $26,793
-490 Reduced 3.6%
13,115 $692,000
Q2 2023

Jul 14, 2023

SELL
$49.72 - $54.64 $35,500 - $39,012
-714 Reduced 4.99%
13,605 $735,000
Q1 2023

Apr 19, 2023

SELL
$45.09 - $50.03 $13,031 - $14,458
-289 Reduced 1.98%
14,319 $716,000
Q4 2022

Feb 06, 2023

SELL
$39.56 - $47.22 $31,727 - $37,870
-802 Reduced 5.2%
14,608 $676,000
Q3 2022

Nov 02, 2022

BUY
$36.71 - $109.66 $22,613 - $67,550
616 Added 4.16%
15,410 $597,000
Q2 2022

Jul 27, 2022

SELL
$35.24 - $47.1 $845 - $1,130
-24 Reduced 0.16%
14,794 $551,000
Q1 2022

Apr 29, 2022

BUY
$40.9 - $45.1 $23,353 - $25,752
571 Added 4.01%
14,818 $638,000
Q4 2021

Feb 08, 2022

BUY
$38.07 - $44.87 $8,641 - $10,185
227 Added 1.62%
14,247 $605,000
Q3 2021

Nov 03, 2021

SELL
$41.23 - $45.88 $1,278 - $1,422
-31 Reduced 0.22%
14,020 $608,000
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $36,188 - $41,497
938 Added 7.15%
14,051 $601,000
Q1 2021

May 10, 2021

BUY
$35.27 - $39.67 $462,495 - $520,192
13,113 New
13,113 $507,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Navalign, LLC Portfolio

Follow Navalign, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.